Status:
COMPLETED
Food-Effect Pharmacokinetic Study of PL2200
Lead Sponsor:
PLx Pharma
Conditions:
Healthy
Eligibility:
All Genders
21-65 years
Phase:
PHASE1
Brief Summary
This trial is a food-effect study to assess fasted versus fed pharmacokinetics of PL2200.
Eligibility Criteria
Inclusion
- Healthy normal male and female volunteers between 21 and 65 years of age.
Exclusion
- Abnormal findings on physical examination or clinical laboratories, or significant medical history.
- Subject with hypersensitivity or contraindications to aspirin, ibuprofen, or other nonsteroidal anti-inflammatory drug (NSAID).
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01244100
Start Date
October 1 2010
Last Update
December 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Houston Institute for Clinical Research
Houston, Texas, United States, 77074